Advisornet Financial’s PTC Therapeutics PTCT Stock Holding History

Advisornet Financial’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.41K	Hold	54	–	–	﹤0.01%	1785
2026 Q1	$3.68K	Sell	54 -38	-41%	-$2.69K	﹤0.01%	1798
2025 Q4	$6.99K	Buy	92 +38	+70%	+$2.76K	﹤0.01%	1659
2025 Q3	$3.31K	Buy	54 +27	+100%	+$1.41K	﹤0.01%	1774
2025 Q2	$1.32K	Hold	27	–	–	﹤0.01%	1903
2025 Q1	$1.38K	Hold	27	–	–	﹤0.01%	1845
2024 Q4	$1.22K	Hold	27	–	–	﹤0.01%	1676
2024 Q3	$1K	Buy	+27	New	+$904	﹤0.01%	1942
2024 Q1	–	Sell	-6	Closed	-$165	–	2411
2023 Q4	$165	Buy	6 +5	+500%	+$114	﹤0.01%	2323
2023 Q3	$22	Sell	1 -3	-75%	-$112	﹤0.01%	2265
2023 Q2	$163	Hold	4	–	–	﹤0.01%	2240
2023 Q1	$194	Buy	4 +2	+100%	+$91	﹤0.01%	2253
2022 Q4	$76	Buy	+2	New	+$83	﹤0.01%	2312

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Advisornet Financial's PTCT Position: Q2 2026 in Review

Advisornet Financial held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 54 shares worth $4.41K. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

Advisornet Financial first reported a position in PTCT in Q4 2022 and has held it in 13 quarters since. The position peaked at $6.99K in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Advisornet Financial held 54 shares of PTC Therapeutics worth $4.41K as of Q2 2026.
Advisornet Financial left its PTC Therapeutics share count unchanged in Q2 2026.
PTC Therapeutics made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1785 holding.
Advisornet Financial first reported a position in PTC Therapeutics in Q4 2022 and has held it in 13 quarters since.
Advisornet Financial's PTC Therapeutics position peaked at $6.99K in Q4 2025.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.